• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞腺瘤。来自一家肝胆专科单位的12年手术经验。

Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

作者信息

Leese T, Farges O, Bismuth H

机构信息

Hepatobiliary Unit, Hôpital Paul Brousse, Villejuif, France.

出版信息

Ann Surg. 1988 Nov;208(5):558-64. doi: 10.1097/00000658-198811000-00003.

DOI:10.1097/00000658-198811000-00003
PMID:3190282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1493795/
Abstract

Twenty-four patients with liver cell adenomas were referred to Paul Brousse Hospital between 1976 and 1987. This represents the largest reported surgical experience of this pathology from a single centre. Six patients had multiple adenomas, which were associated with glycogen storage disease in four. Two patients had polyadenomatosis, one of whom underwent successful liver transplantation after malignant transformation to hepatocellular carcinoma. Eighteen patients (median age of 33 years, range of 17-45 years) had either a solitary adenoma or two adenomas. Eighty-three per cent were women 87% of whom had received oral contraceptives or other hormone therapy before diagnosis (median duration of 11 years, range of 3-15 years). Fifty per cent of these patients presented with acute hemorrhage into an adenoma. Seventeen patients underwent surgical resection of their adenomas, with the remaining patient currently being treated by arterial embolizations to reduce the tumor size before surgery. There was no operative mortality or serious morbidity, and all patients remain well upon follow-up. Surgical excision of liver adenomas, where this can be done without causing mortality, is recommended. Resection relieves symptoms and removes both the risks of hemorrhaging into the tumour and of malignant transformation to hepatocellular carcinoma.

摘要

1976年至1987年间,24例肝细胞腺瘤患者被转诊至保罗·布罗斯医院。这是单个中心报告的关于这种病理情况的最大规模手术经验。6例患者有多个腺瘤,其中4例与糖原贮积病相关。2例患者有多发性腺瘤病,其中1例在恶变为肝细胞癌后接受了成功的肝移植。18例患者(中位年龄33岁,范围17 - 45岁)有单个腺瘤或两个腺瘤。83%为女性,其中87%在诊断前接受过口服避孕药或其他激素治疗(中位持续时间11年,范围3 - 15年)。这些患者中有50%表现为腺瘤急性出血。17例患者接受了腺瘤的手术切除,其余患者目前正在接受动脉栓塞治疗以在手术前缩小肿瘤大小。无手术死亡或严重并发症,所有患者在随访中情况良好。建议在不导致死亡的情况下对肝腺瘤进行手术切除。切除可缓解症状,并消除肿瘤内出血和恶变为肝细胞癌的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/1493795/a83182bfa97d/annsurg00189-0031-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/1493795/47debd4d1707/annsurg00189-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/1493795/a83182bfa97d/annsurg00189-0031-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/1493795/47debd4d1707/annsurg00189-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/1493795/a83182bfa97d/annsurg00189-0031-b.jpg

相似文献

1
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.肝细胞腺瘤。来自一家肝胆专科单位的12年手术经验。
Ann Surg. 1988 Nov;208(5):558-64. doi: 10.1097/00000658-198811000-00003.
2
Hepatic adenoma and focal nodular hyperplasia.肝腺瘤和局灶性结节性增生。
Surg Gynecol Obstet. 1991 Nov;173(5):426-31.
3
[Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].[长期使用口服避孕药患者肝腺瘤转变为肝细胞癌]
Rev Hosp Clin Fac Med Sao Paulo. 1994 Jan-Feb;49(1):30-3.
4
[Spontaneous hemorrhage in liver neoplasms. Experience at an institution].
Rev Gastroenterol Mex. 1998 Jul-Sep;63(3):126-30.
5
The malignant transformation of liver cell adenomas.肝细胞腺瘤的恶性转化。
Arch Surg. 1994 Jul;129(7):712-7. doi: 10.1001/archsurg.1994.01420310044007.
6
Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature.肝腺瘤出血与Ia型糖原贮积病:一例报告并文献复习
Surgery. 1985 Jan;97(1):117-24.
7
Management issues regarding hepatic adenomatosis.
Am Surg. 1999 Nov;65(11):1070-6.
8
[Surgical timing in bleeding liver adenoma: case report].[出血性肝腺瘤的手术时机:病例报告]
G Chir. 2007 Oct;28(10):390-3.
9
Selective management of hepatic adenomas.肝腺瘤的选择性管理。
Am Surg. 1996 Oct;62(10):825-9.
10
[Hepatocellular adenoma in 20 patients; recommendations for treatment].[20例肝细胞腺瘤患者;治疗建议]
Ned Tijdschr Geneeskd. 1998 Nov 7;142(45):2459-63.

引用本文的文献

1
Long-term Outcomes (10 years) of Hepatic Transplantation in a Patient with Hepatic Adenomatosis: A Case Report.肝腺瘤病患者肝移植的长期结局(10年):一例报告
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S4126-S4129. doi: 10.4103/jpbs.jpbs_754_24. Epub 2024 Sep 11.
2
Hepatocellular adenomas with severe intra-abdominal bleeding, related to an underlying coagulation disorder: a case report.伴有严重腹腔内出血的肝细胞腺瘤,与潜在的凝血障碍相关:一例报告。
J Med Case Rep. 2024 Aug 13;18(1):367. doi: 10.1186/s13256-024-04709-7.
3
Surgical Management of a Giant Inflammatory Hepatocellular Adenoma in a Young Female.

本文引用的文献

1
Surgical anatomy and anatomical surgery of the liver.肝脏的外科解剖学与解剖学手术
World J Surg. 1982 Jan;6(1):3-9. doi: 10.1007/BF01656368.
2
Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.Ia型糖原贮积病中肝腺瘤经饮食治疗后的消退
Gastroenterology. 1981 Sep;81(3):534-6.
3
Experience with 150 liver resections.150例肝切除术的经验。
一名年轻女性巨大炎性肝细胞腺瘤的手术治疗
Cureus. 2024 Jun 10;16(6):e62097. doi: 10.7759/cureus.62097. eCollection 2024 Jun.
4
Imaging features and management of focal liver lesions.肝脏局灶性病变的影像学特征与管理
World J Radiol. 2024 Jun 28;16(6):139-167. doi: 10.4329/wjr.v16.i6.139.
5
Case Report: Hepatic Adenomatosis in a Patient With Prader-Willi Syndrome.病例报告:普瑞德-威利综合征患者的肝腺瘤。
Front Endocrinol (Lausanne). 2022 Mar 9;13:826772. doi: 10.3389/fendo.2022.826772. eCollection 2022.
6
Living Donor Liver Transplantation as a Backup Procedure: Treatment Strategy for Hepatocellular Adenomas Requiring Complex Resections.活体肝移植作为一种备用手术:对需要复杂切除的肝细胞腺瘤的治疗策略
Case Rep Surg. 2022 Feb 17;2022:1015061. doi: 10.1155/2022/1015061. eCollection 2022.
7
KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study.生酮饮食疗法治疗肝细胞腺瘤患者:一项配对干预队列研究的研究方案。
BMJ Open. 2022 Feb 15;12(2):e053559. doi: 10.1136/bmjopen-2021-053559.
8
Non-traumatic spontaneous ruptured hepatocellular adenoma after selective transcatheter arterial chemo-embolization for reduction of tumor mass: A case report.选择性经导管动脉化疗栓塞术降低肿瘤体积后非创伤性自发性肝细胞腺瘤破裂:病例报告。
Ulus Travma Acil Cerrahi Derg. 2022 Jan;28(2):225-228. doi: 10.14744/tjtes.2020.94838.
9
Liver Transplantation for Hepatic Adenoma: A UNOS Database Analysis and Systematic Review of the Literature.肝腺瘤的肝移植:一项器官共享联合网络数据库分析及文献系统综述
Transplant Direct. 2022 Jan 5;8(2):e1264. doi: 10.1097/TXD.0000000000001264. eCollection 2022 Feb.
10
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia.肝脏碰撞性病变:局灶性结节性增生内的炎性肝细胞腺瘤。
Gastroenterol Rep (Oxf). 2020 Dec 14;9(4):374-376. doi: 10.1093/gastro/goaa074. eCollection 2021 Aug.
Ann Surg. 1983 Mar;197(3):247-53. doi: 10.1097/00000658-198303000-00001.
4
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.肝腺瘤与局灶性结节性增生:临床、病理及影像学特征
Gastroenterology. 1983 May;84(5 Pt 1):994-1002.
5
Androgen related primary hepatic tumors in non-Fanconi patients.
Cancer. 1983 May 15;51(10):1947-52. doi: 10.1002/1097-0142(19830515)51:10<1947::aid-cncr2820511034>3.0.co;2-5.
6
Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives.停用口服避孕药后肝细胞腺瘤完全消退。
Dig Dis Sci. 1981 Nov;26(11):1045-50. doi: 10.1007/BF01314771.
7
Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.肝细胞腺瘤。口服避孕药使用者中其向癌的转变。
Arch Pathol Lab Med. 1981 Jun;105(6):296-9.
8
Resection of primary solid hepatic tumors.原发性肝脏实体肿瘤切除术。
Am J Surg. 1981 Jan;141(1):18-21. doi: 10.1016/0002-9610(81)90005-2.
9
Liver transplantation for type I glycogen storage disease.I型糖原贮积病的肝移植
Lancet. 1983 May 14;1(8333):1073-5. doi: 10.1016/s0140-6736(83)91910-4.
10
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis.口服避孕药相关的肝脏肿瘤:恶性肿瘤的发生及诊断困难
Lancet. 1980 Feb 9;1(8163):273-6. doi: 10.1016/s0140-6736(80)90776-x.